<![CDATA[Agendia, Inc. 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=37250>Fri, 01 May 2026 04:31:23 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[Agendia’s MammaPrint® Test is the First to Demonstrate the Ability to Predict Benefit from Extended Endocrine Treatment in NSABP B-42 Trial]]>https://www.newswire.co.kr/newsRead.php?no=924927Tue, 08 Jun 2021 16:40:00 +0900<![CDATA[아젠디아의 맘마프린트 검사, NSABP B-42 임상시험서 연장된 내분비 요법의 효능을 예측할 수 있는 것으로 처음 입증]]>https://www.newswire.co.kr/newsRead.php?no=924928Tue, 08 Jun 2021 16:40:00 +0900<![CDATA[Analysis of MINDACT Study Confirms MammaPrint Accurately Identifies Extremely Indolent Ultra Low Risk Breast Cancers]]>https://www.newswire.co.kr/newsRead.php?no=924819Mon, 07 Jun 2021 11:50:00 +0900<![CDATA[MINDACT 연구 분석, 맘마프린트 검사가 무통성 초저위험군 유방암을 정확하게 식별한다고 밝혀]]>https://www.newswire.co.kr/newsRead.php?no=924820Mon, 07 Jun 2021 11:50:00 +0900<![CDATA[Agendia Presents Data from Innovative FLEX Study at ASCO 2021 Showing MammaPrint and BluePrint Utility in Wide Variety of Patient Populations]]>https://www.newswire.co.kr/newsRead.php?no=924802Mon, 07 Jun 2021 11:10:00 +0900<![CDATA[아젠디아, 2021 미국 임상종양학회에서 혁신적인 FLEX 연구 데이터 제시… 다양한 환자 집단에서 맘마프린트 및 블루프린트 유틸리티 보여줘]]>https://www.newswire.co.kr/newsRead.php?no=924803Mon, 07 Jun 2021 11:10:00 +0900<![CDATA[ASCO 2021 Podium Presentation on Agendia FLEX Study Shows Clinical & Molecular Differences in Tumors of African American and Caucasian Patients with HR+ Breast Cancer, Underscores Importance of Genomic Insights to Understand Disparities in Outcomes]]>https://www.newswire.co.kr/newsRead.php?no=924799Mon, 07 Jun 2021 10:50:00 +0900<![CDATA[아젠디아, ASCO 2021에서 FLEX 연구 결과 발표]]>https://www.newswire.co.kr/newsRead.php?no=924800Mon, 07 Jun 2021 10:50:00 +0900<![CDATA[Landmark Long-Term Data from EORTC’s MINDACT Study Published in The Lancet Oncology]]>https://www.newswire.co.kr/newsRead.php?no=919992Mon, 15 Mar 2021 12:00:00 +0900<![CDATA[EORTC ‘MINDACT 연구’ 대한 대규모 장기 데이터, ‘란셋 온콜로지’에 발표돼]]>https://www.newswire.co.kr/newsRead.php?no=919993Mon, 15 Mar 2021 12:00:00 +0900